Comparison of dose-adjusted EPOCH-R and R-CHOP in diffuse large B-cell lymphoma with high Ki67 expression: Results from a prospective observational study
Wenxin Jiang, Peng Liu · 2026
Read Comparison of dose-adjusted EPOCH-R and R-CHOP in diffuse large B-cell lymphoma with high Ki67 expression: Results from a prospective observational study by Wenxin Jiang, Peng Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0350024.txt.
Description
Wenxin Jiang and Peng Liu compared two chemotherapy regimens for diffuse large B-cell lymphoma, a fast-growing blood cancer, in patients whose tumors showed a high growth marker. One regimen adjusts doses upward over cycles, and the other is the long-standing standard. Earlier records from three hundred seventy-six patients set the marker level that counts as high.
Twenty-nine patients received the dose-adjusted regimen in a forward-looking study, matched against similar patients who got the standard one. Survival without the disease returning, and overall survival, did not differ meaningfully between the groups. Enrollment stopped early because benefit looked unlikely and recruitment was slow. For doctors, the result argues against choosing the harsher regimen on growth marker alone.
Catalog record
| CREATOR | Wenxin Jiang, Peng Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25210 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |